Role of myocardial perfusion imaging after coronary revascularization in symptom-free patients: Are low-risk patients really low?

Journal of Nuclear Cardiology

Volumn 9, Issue 5, 2002, Pages 550-553

  Angiolillo, Dominick Joseph ^a   Giordano, Alessandro ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; RADIOISOTOPE; THALLIUM 201;

ANGINA PECTORIS; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; EDITORIAL; ELECTROCARDIOGRAPHY; EXERCISE TEST; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HEART SCINTISCANNING; HEART STRESS; HIGH RISK PATIENT; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RESTENOSIS; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOM; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

EID: 0036765324     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1067/mnc.2002.124476     Document Type: Editorial

References (37)

1. Miller DD. Radionuclide assessment of coronary artery disease following revascularization. In: Gerson MC, ed. Cardiac nuclear medicine, 3rd ed. New York: McGraw-Hill; 1997. p. 609-18.
2. Brown KA. Prognostic value of nuclear cardiology techniques. In: Gerson MC, ed. Cardiac nuclear medicine, 3rd ed. New York: McGraw-Hill; 1997. p. 619-54.
3. Brown KA, Rowen M. Prognostic value of a normal exercise myocardial perfusion imaging study in patients with angiographically significant coronary artery disease. Am J Cardiol 1993;71:865-7.
4. Ladenheim ML, Pollock BH, Rozanski A, Berman DS, Staniloff HM, Forrester JS, et al. Extent and severity of myocardial reperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol 1986;7:464-71.
5. Abdel Fattah A, Kamal AM, Pancholy S, Ghods M, Russell J, Cassel D, et al. Prognostic implications of normal exercise tomographic thallium images in patients with angiographic evidence of significant coronary artery disease. Am J Cardiol 1994;74:769-71.
6. Stuckey TD, Burwell LR, Nygaard TW, Gibson RS, Watson DD, Beller GA. Quantitative exercise thallium-201 scintigraphy for predicting angina recurrence after percutaneous transluminal coronary angioplasty (PTCA). J Nucl Med 1989;63:517-21.
7. Milan E, Moretti R, Terzi A, Rossinim P, Libretti R, Mostarda A, et al. Prognostic implications of normal single photon computed tomography (SPECT) after percutaneous transluminal coronary angioplasty (PTCA). J Nucl Med 1998;39(Suppl):115P.
8. Borges-Neto S, Shaw LJ, Kesler K, Sell T, Peterson ED, Coleman RE, et al. Usefulness of serial radionuclide angiography in predicting cardiac death after coronary artery bypass grafting and comparison with clinical and catheterization data. Am J Cardiol 1997;79:851-5.
9. Kaminek M, Myslivecek M, Skvarilova M, Husak V, Koranda P, Lang O. Prognostic value of myocardial perfusion tomographic imaging in patients after percutaneous transluminal coronary angioplasty. Clin Nucl Med 2000;25:775-8.
10. Ho KT, Miller TD, Holmes DR, Hodge DO, Gibbons RJ. Long-term prognostic value of Duke treadmill score and exercise thallium-201 imaging performed one to three years after percutaneous transluminal coronary angioplasty. Am J Cardiol 1999;84:1323-7.
11. Manyari DE, Knudtson M, Kloiber R, Roth D. Sequential thallium-201 myocardial perfusion studies after successful percutaneous transluminal coronary angioplasty: delayed resolution of exercise-induced scintigraphic abnormalities. Circulation 1988;77:86-95.
12. Wijns W, Serruys PW, Simoons ML, van den Brand M, de Feijter PJ, Reiber JH, et al. Predictive value of early exercise test and thallium scintigraphy after successful percutaneous transluminal coronary angioplasty. Br Heart J 1985;53:194-200.
13. Jain A, Mahmarian JJ, Borges-Neto S, Johnston DL, Cashion WR, Lewis JM, et al. Clinical significance of perfusion defects by thallium-201 single photon emission tomography following oral dipyridamole early after coronary angioplasty. J Am Coll Cardiol 1988;11:970-6.
14. Yusuf S, Zucker D, Peduzzi P, Fischer LD, Takaro T, Kennedy JW, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Trialists Collaboration. Lancet 1994;344:563-70.
15. Kafka H, Leach AJ, Fitzgibbon GM. Exercise echocardiography after coronary artery bypass surgery: correlation with coronary angiography. J Am Coll Cardiol 1995;25:1019-25.
16. Kawasuji M, Tedoriya T, Sakakibara N, Takahashi M, Taki J, Watanabe Y. Silent left ventricular dysfunction during exercise after coronary artery bypass surgery. Eur J Cardiothorac Surg 1991;5:618-22.
17. Serruys PW, de-Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994;331: 489-95.
18. Fischman DL, Leon MB, Bairn DS, Schatz RA, Savage MP, Penn I, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
19. Schomig A, Kastrati A, Mudra H, Blasini R, Schhlen H, Klauss V, et al. Four year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure. Circulation 1994;90:2716-24.
20. Savage MP, Fischman DL, Schatz RA, Teirstein PS, Leon MB, Baim D, et al. Long-term angiographic and clinical outcome after implantation of balloon-expandable stent in the native coronary circulation. Palmaz-Schatz Stent Study Group. J Am Coll Cardiol 1994;24:1207-12.
21. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. The EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. Lancet 1998; 352:87-92.
22. Hernandez RA, Macaya C, Iniguez A, Alfonso F, Goicolea J, Fernandez-Ortiz A, et al. Midterm outcome of patients with asymptomatic restenosis after coronary balloon angioplasty. J Am Coll Cardiol 1992;19:1402-9.
23. Hecht HS, Shaw RS, Bruce TR, Ryan C, Stertzer SH, Myler RK. Usefulness of tomographic thallium-201 imaging for detection of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1990;6:1314-8.
24. Hecht HS, Shaw RS, Chin HL, Ryan C, Stertzer SH, Myler RK. Silent ischemia after coronary angioplasty: evaluation of restenosis and extent of ischemia in asymptomatic patients by tomographic thallium-201 exercise imaging and comparison with symptomatic patients. J Am Coll Cardiol 1991;17:670-7.
25. O'Keefe J, Lapeyre AC III, Holmes DR, Gibbons RJ. Usefulness of early radionuclide angiography for identifying low-risk patients for late restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1988;61:51-4.
26. Mishra JP, Iskandrian AE. Stress myocardial perfusion imaging after coronary angioplasty. Am J Cardiol 1998;81:766-9.
27. Proceedings of the 4th Invitational Wintergreen Conference. J Nucl Cardiol 1999;6(1 pt 1):931-55.
28. ACC/AHA Task Force. Guidelines for clinical use of cardiac radionuclide imaging. J Am Coll Cardiol 1995;25:521-47.
29. ANMCO-SIC-GICN-AIMN guidelines of the appropriate use of nuclear medicine methods in cardiology [in Italian]. G Ital Cardiol 1999;29:943-81.
30. Lauer MS, Lytle B, Pashkow, Snader CE, Marwick TH. Prediction of death and myocardial infarction by screening with exercise-thallium testing after coronary-artery-bypass grafting. Lancet 1998;351:615-22.
31. Heller LI, Tresgallo M, Sciacca RR, Blood DK, Seldin DW, Johnson LL. Prognostic significance of silent myocardial ischemia on a thallium stress test. Am J Cardiol 1990;65:718-21.
32. Pfisterer M, Rickenbacher P, Kiowski W, Muller-Brand J, Burkart F. Silent ischemia after percutaneous transluminal coronary angioplasty: incidence and prognostic significance. J Am Coll Cardiol 1993;22:1446-54.
33. King SB III, Lembo NJ, Weintraub WS, et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST). N Engl J Med 1994;331:1044-50.
34. Alazraki NP, Krawczynska EG, Konsinski AS, DePuey EG, Ziffer JA, Taylor AT, et al. Quantitative thallium single photon emission computed tomography predicts risk for poor outcome in the Emory Angioplasty versus Surgery Trial. Circulation 1995;92(Suppl 1):521.
35. Alazraki NP, Krawczynska EG. Thallium imaging in management of post-revascularization patients. Q J Nucl Med 1996;40:85-90.
36. Alazraki NP, Krawczynska EG, Konsinski AS, De Puey EG III, Ziffer JA, Taylor AT Jr, et al. Prognostic value of thallium-201 single-photon emission computed tomography for patients with multivessel coronary artery disease after revascularization (The Emory Angioplasty versus Surgery Trial [EAST]). Am J Cardiol 1999;84:1369-74.
37. Mak KH, Eisenberg MJ, Shaw J. Cost-efficacy modeling of functional testing with perfusion imaging to detect asymptomatic restenosis following percutaneous transluminal coronary angioplasty. Catheter Cardiovasc Interv 1999;48:352-6.